Trial Profile
Anti-Inflammatory Therapy to Augment CF transmembrane conductance regulator (CFTR) Rescue in Cystic Fibrosis (CF) Patients
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 12 May 2023
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications Cystic fibrosis
- Focus Proof of concept; Therapeutic Use
- 08 May 2023 Planned End Date changed from 31 Dec 2022 to 31 Mar 2024.
- 08 May 2023 Planned primary completion date changed from 31 Aug 2022 to 31 Mar 2024.
- 25 Oct 2021 Planned End Date changed from 31 May 2022 to 31 Dec 2022.